Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 16, 2025Frontiers in MedicineOpen Access

Telitacicept administration improved immunoglobulin A nephropathy after hematopoietic stem cell transplantation: a case report

View Full Paper
Ask AI
Bookmark
Share

Authors

ZYZengrong YuanDDDan DongZLZhang Li

Discussion

Loading...

Member takes

Overview

Case report shows telitacicept improves IgAN after HSCT in a patient with AML, suggesting possible broader applications.

Key Points

  • Telitacicept administration led to significant improvement in nephrotic syndrome among the patient.
  • Urinary protein level decreased from 8.28 g to 0.23 g/24 h post-treatment.
  • Estimated glomerular filtration rate improved from 67.3 to 79.83 mL/min after treatment.
  • The patient experienced stable conditions without significant adverse effects during glucocorticoid tapering.

Cite This Study

Yuan et al. (2025) studied this question.

synapsesocial.com/papers/68d4538f31b076d99fa58cb7https://doi.org/10.3389/fmed.2025.1667519
View Full Paper
Ask AI
Bookmark
Share